{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:24:56Z","timestamp":1793942696922,"version":"4.8.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-03291-18"],"award-info":[{"award-number":["APQ-03291-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310749\/2022-0"],"award-info":[{"award-number":["310749\/2022-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hrthm.2025.12.037","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:25:01Z","timestamp":1767831901000},"page":"e1329-e1346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Can oral anticoagulants be safely discontinued after atrial fibrillation ablation? A systematic review and meta-analysis of reconstructed time-to-event data"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3408-2115","authenticated-orcid":false,"given":"Lucas M.","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Martins Rodrigues","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Curi Barbosa Izoton","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo N.","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.R.","family":"Defante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludimilla Pereira","family":"Tartuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do Carmo P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno R.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia O.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto Graner","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.12.037_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/heartjnl-2020-318676","article-title":"Quality of life and healthcare utilisation improvements after atrial fibrillation ablation","volume":"107","author":"Gupta","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2025.12.037_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.hrthm.2025.05.021","article-title":"Ablation of atrial fibrillation and risk of stroke: a meta-analysis","volume":"23","author":"Providencia","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.12.037_bib3","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.hrthm.2024.03.017","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"21","author":"Tzeis","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.12.037_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"334","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.12.037_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"Verma","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00392-023-02319-9","article-title":"Prevention of cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation: the ODIn-AF trial","volume":"113","author":"Schrickel","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib7","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2025.12.037_bib8","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.12.037_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/1536867X1801700402","article-title":"Reconstructing time-to-event data from published Kaplan-Meier curves","volume":"17","author":"Wei","year":"2017","journal-title":"Stata J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.hrthm.2025.12.037_bib14","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12350-019-01624-z","article-title":"Landmark analysis: a primer","volume":"26","author":"Morgan","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib17","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.4088\/JCP.15f09870","article-title":"The numbers needed to treat and harm (NNT, NNH) statistics: what they tell us and what they do not","volume":"76","author":"Andrade","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.hrthm.2025.12.037_bib18","first-page":"30","article-title":"Bayesian analytical methods in cardiovascular clinical trials: why, when, and how","volume":"41","author":"Heuts","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib19","first-page":"88","article-title":"Are we missing the forest for the trees? How Bayesian meta-analysis could reshape evidence in cardiology","volume":"107","author":"Oliveira","year":"2026","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2025.12.037_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamainternmed.2020.1647","article-title":"Bayesian interpretation of the EXCEL trial and other randomized clinical trials of left main coronary artery revascularization","volume":"180","author":"Brophy","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib21","article-title":"Bayesian and Markov chain Monte Carlo methods for identifying nonlinear systems in the presence of uncertainty","volume":"373","author":"Green","year":"2015","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.hrthm.2025.12.037_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-020-00001-2","article-title":"Bayesian statistics and modelling","volume":"1","author":"van de Schoot","year":"2021","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.hrthm.2025.12.037_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00134-021-06602-z","article-title":"Pick your prior: scepticism about sceptical prior beliefs","volume":"48","author":"de Grooth","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib24","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/jce.70069","article-title":"Bayesian evaluation of pentaspline pulsed field ablation compared to high-power radiofrequency ablation in atrial fibrillation","volume":"36","author":"Barbosa","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib25","article-title":"Bayesian insights into fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention in patients with myocardial infarction","author":"Barbosa","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003563","article-title":"Bayesian analysis: a practical approach to interpret clinical trials and create clinical practice guidelines","volume":"10","author":"Bittl","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrthm.2025.12.037_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(20)30471-9","article-title":"Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?","volume":"9","author":"Yarnell","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials: an overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.hrthm.2025.12.037_bib30","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.12.037_bib31","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.12.037_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.12.037_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.12.037_bib34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.12.037_bib35","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s10840-025-02109-5","article-title":"Assessing the role of ICD in Chagas heart disease: a systematic review, meta-analysis, and meta-regression","volume":"68","author":"Barbosa","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1536\/ihj.18-517","article-title":"Adverse clinical events during long-term follow-up after catheter ablation of atrial fibrillation","volume":"60","author":"Arai","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib37","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1540-8167.2009.01481.x","article-title":"Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures","volume":"20","author":"Bunch","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32516","article-title":"Real world risk of discontinuing oral anticoagulation after successful catheter ablation for atrial fibrillation","volume":"10","author":"Fei","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.hrthm.2025.12.037_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2459\/JCM.0000000000000311","article-title":"Long-term events following atrial fibrillation rate control or transcatheter ablation: a multicenter observational study","volume":"17","author":"Gallo","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.hrthm.2025.12.037_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1540-8167.2011.02141.x","article-title":"Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly","volume":"23","author":"Guiot","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2020.08.005","article-title":"Long-term incidence and predictive factors of thromboembolic events after a cryoballoon ablation for atrial fibrillation","volume":"321","author":"Hermida","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/heartjnl-2011-300720","article-title":"Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death","volume":"98","author":"Hunter","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2025.12.037_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCEP.111.962100","article-title":"Natural history and long-term outcomes of ablated atrial fibrillation","volume":"4","author":"Hussein","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jjcc.2020.09.001","article-title":"Long-term efficacy and safety of anticoagulation after atrial fibrillation ablation: data from the JACRE registry","volume":"77","author":"Inoue","year":"2021","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.1320","article-title":"Discontinuation of oral anticoagulation after successful atrial fibrillation ablation","volume":"8","author":"Iwawaki","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2025.12.037_bib46","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/eurheartj\/ehad798","article-title":"Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks","volume":"45","author":"Kanaoka","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/jce.13138","article-title":"Risk of stroke and recurrence after AF ablation in patients with an initial event-free period of 12 months","volume":"28","author":"Kochh\u00e4user","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib49","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jocs.14719","article-title":"Discontinuation of anticoagulants after successful surgical ablation of atrial fibrillation","volume":"35","author":"Lauritzen","year":"2020","journal-title":"J Card Surg"},{"key":"10.1016\/j.hrthm.2025.12.037_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jce.13476","article-title":"Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation","volume":"29","author":"Liang","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib51","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2007.10.044","article-title":"Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation","volume":"51","author":"Nademanee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jjcc.2025.04.004","article-title":"Association between oral anticoagulants continuation on thromboembolism and bleeding events in patients with CHADS2 score 0-2 points after catheter ablation for persistent atrial fibrillation","volume":"86","author":"Nakano","year":"2025","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/anec.70067","article-title":"Assessment of long-term use versus discontinuation of direct oral anticoagulant after catheter ablation for atrial fibrillation\u2014RYOUMA registry subanalysis","volume":"30","author":"Oda","year":"2025","journal-title":"Ann Noninvas Electrocardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib54","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1253\/circj.CJ-19-0602","article-title":"Current status and clinical outcomes of oral anticoagulant discontinuation after ablation for atrial fibrillation in Japan\u2014findings from the AF Frontier Ablation Registry","volume":"83","author":"Okumura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","article-title":"Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation","volume":"114","author":"Oral","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.12.037_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jce.12387","article-title":"Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment","volume":"25","author":"Riley","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCEP.111.963231","article-title":"Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score \u22643: a long-term outcome study","volume":"4","author":"Saad","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jamacardio.2016.4179","article-title":"Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation","volume":"2","author":"Sj\u00e4lander","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib59","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib60","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3349\/ymj.2014.55.5.1238","article-title":"Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation","volume":"55","author":"Uhm","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10840-013-9835-1","article-title":"Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes","volume":"38","author":"Winkle","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib62","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1253\/circj.CJ-11-0065","article-title":"Incidence of late thromboembolic events after catheter ablation of atrial fibrillation","volume":"75","author":"Yagishita","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/europace\/euz235","article-title":"The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study","volume":"22","author":"Yang","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.12.037_bib64","doi-asserted-by":"crossref","first-page":"940","DOI":"10.21037\/apm-20-565","article-title":"Real-world investigation on discontinuation of oral anticoagulation after paroxysmal atrial fibrillation catheter ablation in China","volume":"9","author":"Yu","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0107","article-title":"Outcomes associated with oral anticoagulants plus antiplatelets in patients with newly diagnosed atrial fibrillation","volume":"3","author":"Fox","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2025.12.037_bib66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sj\u00e4lander","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.12.037_bib67","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/STROKEAHA.118.023954","article-title":"Antiplatelet therapy in ischemic stroke and transient ischemic attack","volume":"50","author":"Hackam","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.12.037_bib68","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/europace\/eut406","article-title":"Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation","volume":"16","author":"Gaita","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.12.037_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002597","article-title":"Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.12.037_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221118480","article-title":"Benefits and risks associated with long-term oral anticoagulation after successful atrial fibrillation catheter ablation: systematic review and meta-analysis","volume":"28","author":"Maduray","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.hrthm.2025.12.037_bib71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","article-title":"Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation","volume":"135","author":"Quinn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.12.037_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2018.08.096","article-title":"Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: a cluster randomised trial in general practice","volume":"273","author":"van Doorn","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib73","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib74","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/eurheartj\/ehr342","article-title":"Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment","volume":"32","author":"Fox","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib75","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"33","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib76","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.12.037_bib77","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/s41591-024-03049-9","article-title":"Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk","volume":"30","author":"Mobley","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.hrthm.2025.12.037_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"Corica","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.12.037_bib79","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.12.037_bib80","article-title":"Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"Teppo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hrthm.2025.12.037_bib81","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.hrthm.2025.05.067","article-title":"Stroke risks in women vs men in Asian patients with atrial fibrillation: a temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores","volume":"22","author":"Cheng","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.12.037_bib82","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1055\/a-1807-0336","article-title":"Early rhythm control and the risks of ischemic stroke, heart failure, mortality, and adverse events when performed early (<3 months): a nationwide cohort study of newly diagnosed patients with atrial fibrillation","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.12.037_bib83","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jce.14052","article-title":"Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: a systematic review and meta-analysis","volume":"30","author":"Romero","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib84","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.12.037_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40256-015-0123-6","article-title":"Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOACs)","volume":"15","author":"Werth","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hrthm.2025.12.037_bib86","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","article-title":"Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry","volume":"124","author":"Beyer-Westendorf","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.hrthm.2025.12.037_bib87","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.12.037_bib88","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.12.037_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae134","article-title":"State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective","volume":"26","author":"Chun","year":"2024","journal-title":"Europace"}],"updated-by":[{"DOI":"10.1016\/j.hrthm.2026.08.017","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:38:47Z","timestamp":1793939927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1547527126000032"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.12.037","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can oral anticoagulants be safely discontinued after atrial fibrillation ablation? A systematic review and meta-analysis of reconstructed time-to-event data","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}